Appointment booking for Dr. Leonidas Vieron, MD is currently not available.Dr. Leonidas Vieron, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Leonidas Vieron, MD (he/him) is a Internist in Memphis, TN with over 17 years of experience. What is your opinion of Dr. Leonidas Vieron, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 17 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Leonidas Vieron, MD has received over $1,132 which includes payments from the following companies:
$233.90 from Janssen Pharmaceuticals, Inc
$168.16 from Otsuka America Pharmaceutical, Inc.
$136.97 from Genentech USA, Inc.
$115.64 from Pfizer Inc.
$113.30 from Amgen Inc.
$57.15 from Takeda Pharmaceuticals America, Inc.
$51.91 from Daiichi Sankyo Inc.
$51.34 from AstraZeneca Pharmaceuticals LP
$38.37 from Valeant Pharmaceuticals North America LLC
$37.68 from Iroko Pharmaceuticals, LLC
$32.13 from Boehringer Ingelheim Pharmaceuticals, Inc.
$17.23 from AbbVie, Inc.
$14.16 from Amarin Pharma Inc.
$14.13 from LILLY USA, LLC
$13.88 from Medtronic USA, Inc.
$13.02 from Medtronic Sofamor Danek USA, Inc.
$12.86 from sanofi-aventis U.S. LLC
$11.02 from Allergan Inc.
Payments received by Dr. Leonidas Vieron, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!